News

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...
U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...
Denmark-based multinational pharmaceutical company Novo Nordisk will be making available in the Philippines within this year Wegovy, its approved weight loss treatment for ...
In the US, Baqsimi is now competing head-to-head with Xeris’ Gvoke, pre-filled syringe and pen injector formulations of glucagon that don’t require the mixing steps and can be used in patients ...
On Tuesday, Camurus (OTC:CAMRF) and Eli Lilly and Company (NYSE: LLY) entered into a collaboration and license agreement. This agreement grants Lilly exclusive, worldwide rights to research, develop, ...
Tirzepatide is the first dual-target therapy that activates both GIP and GLP-1 receptors, helping manage blood sugar levels ...
XP 8121 is a combination drug meant to better control hypothyroidism, in part by moving its common therapy, levothyroxine, from oral dosing into a patient-administered, subcutaneous injection pen. The ...
Mounjaro belongs to a group of drugs called glucagon-like peptide-1 (GLP-1 ... Mounjaro comes as a liquid solution in a prefilled pen containing a single dose of medication.
Camurus (NASDAQ STO: CAMX) and Eli Lilly and Company ("Lilly") have entered a collaboration and license agreement, granting Lilly exclusive, worldwide rights to the research, development, manufacture, ...
With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499 /month or less, regardless of insurance ...
Balancing Acts: The Synergistic Relationship Between Insulin And Glucagon Diabetic Case For Insulin Pen & Needles These hormone interaction dynamics become clear when considering the opposing roles of ...